Y-mAbs Therapeutics, Inc. Other Current Assets
Y-mAbs Therapeutics, Inc. had Other Current Assets of $4.04 million as of 2025-06-30, per its 10-Q filed 2025-08-08.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:OtherAssetsCurrent · last filed 2025-08-08
- 2025-06-30: Other Assets, Current $4.04M.
- 2025-03-31: Other Assets, Current $4.40M.
- 2024-12-31: Other Assets, Current $4.37M.
- 2024-09-30: Other Assets, Current $1.46M.
| Period end | Other Assets, Current |
|---|---|
| 2025-06-30 | $4.04M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $4.40M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $4.37M 10-Q · filed 2025-08-08 |
| 2024-09-30 | $1.46M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $2.24M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $3.48M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $4.96M 10-K · filed 2025-03-04 |
| 2023-09-30 | $2.30M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $3.57M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $3.73M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $5.45M 10-K · filed 2024-02-29 |
| 2022-09-30 | $3.23M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $6.25M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $6.10M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $7.47M 10-K · filed 2023-03-30 |
| 2021-09-30 | $2.80M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $3.44M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $4.74M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $7.73M 10-K · filed 2022-03-01 |
| 2020-09-30 | $1.94M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $5.26M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $4.06M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $4.82M 10-K · filed 2021-03-01 |
| 2019-09-30 | $1.40M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $3.03M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $2.76M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $3.66M 10-K · filed 2020-03-12 |
| 2018-09-30 | $2.72M 10-Q · filed 2018-11-13 |
| 2017-12-31 | $840.00K 10-K · filed 2019-03-22 |